Century Therapeutics Inc (IPSC)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Total Revenue | 521k | 1.72M | 99k | 148k | 268k | 855k | 770k | 791k |
Operating Income | -33.31M | -32.08M | -30.86M | -39.85M | -27.4M | -31.31M | -34.76M | -34.79M |
Pre Tax Income | -31.65M | -30.06M | -32.34M | -32.13M | -40.27M | -28.06M | -31.19M | -31.23M |
Net Income | -31.68M | -31.26M | -33.29M | -32.72M | -39.4M | -28.06M | -31.21M | -31.22M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -35.64M | -32.28M | -31.04M | -39.83M | -27.41M | -31.3M | -34.77M | -34.54M |
EBITDA | -30.47M | -29.17M | -27.62M | -32.28M | -28.07M | -28.08M | -31.3M | -31.49M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 5.2M | 2.24M |
Operating Income | -239.68M | -53.9M | -94.88M | -133.83M | -130.18M |
Pre Tax Income | -238.77M | -53.58M | -95.78M | -130.84M | -134.79M |
Net Income | -238.77M | -53.58M | -95.82M | -130.93M | -136.67M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -31.912 | -7.161 | -1.742 | -2.239 | -2.284 |
EBIT | -238.77M | -53.19M | -94.51M | -133.81M | -130.56M |
EBITDA | -239.5M | -52.5M | -91.14M | -125.39M | -117.14M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.